AngioDynamics, Inc. (ANGO) P/E Ratio History
Deep ValueTrading at -14.6x · 0th percentile of 5-year range · Significant discount to historical valuation · Data 2005–2024
Loading P/E history...
P/E Ratio Analysis
As of June 22, 2026, AngioDynamics, Inc. (ANGO) trades at a price-to-earnings ratio of -14.6x, with a stock price of $12.15 and trailing twelve-month earnings per share of $-0.67.
The current P/E is 116% below its 5-year average of 93.3x. Over the past five years, ANGO's P/E has ranged from a low of 8.9x to a high of 327.1x, placing the current valuation at the 0th percentile of its historical range.
Compared to the Healthcare sector median P/E of 22.1x, ANGO trades at a 166% discount to its sector peers. The sector includes 234 companies with P/E ratios ranging from 0.0x to 197.0x.
Relative to the broader market, ANGO trades at a notable discount to the S&P 500 median P/E of 24.4x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our ANGO DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
ANGO Cross-Benchmark Valuation
How does the current P/E compare to sector peers and the broader market?
ANGO P/E vs Peers
Surgical and interventional devices peers sorted by market cap
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $4B | 31.6 | - | +5% | |
| $3B | 31.5 | 7.15 | -15% | |
| $1B | 21.6 | 0.59 | -65% | |
| $67B | 23.3 | - | +55% | |
| $52B | 24.7 | 1.49 | -1% | |
| $3B | 16.2 | - | +382%Best | |
| $102B | 22.0 | - | +31% | |
| $154B | 11.6Lowest | 0.39Best | +134% |
Lower P/E can signal a discount or weaker growth expectations; PEG adds growth context.
ANGO Historical P/E Data (2005–2024)
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Period End | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2024 Q1 | - | $8.03 | $0.16 | 50.2x | -23% |
| FY2020 Q3 | Feb 29 2020 | $11.49 | $1.28 | 8.9x | -86% |
| FY2020 Q2 | Nov 30 2019 | $15.37 | $1.45 | 10.6x | -84% |
| FY2020 Q1 | Aug 31 2019 | $18.37 | $1.59 | 11.6x | -82% |
| FY2019 Q4 | May 31 2019 | $18.79 | $1.61 | 11.7x | -82% |
| FY2019 Q3 | - | $22.41 | $0.13 | 175.9x | +169% |
| FY2019 Q2 | Nov 30 2018 | $21.49 | $0.48 | 45.0x | -31% |
| FY2019 Q1 | Aug 31 2018 | $22.42 | $0.43 | 52.5x | -20% |
| FY2018 Q4 | - | $21.03 | $0.44 | 47.9x | -27% |
| FY2018 Q3 | Feb 28 2018 | $16.29 | $0.08 | 205.9x | +215% |
| FY2018 Q1 | - | $17.03 | $0.15 | 114.2x | +75% |
| FY2017 Q4 | May 31 2017 | $15.08 | $0.19 | 79.4x | +21% |
| FY2015 Q2 | Nov 30 2014 | $17.50 | $0.16 | 109.8x | +68% |
| FY2015 Q1 | Aug 31 2014 | $14.11 | $0.12 | 121.0x | +85% |
| FY2014 Q4 | May 31 2014 | $14.33 | $0.08 | 169.8x | +160% |
| FY2014 Q3 | Feb 28 2014 | $15.40 | $0.09 | 170.9x | +161% |
| FY2012 Q3 | Feb 29 2012 | $13.02 | $0.04 | 327.1x | +400% |
| FY2012 Q2 | Nov 30 2011 | $15.12 | $0.26 | 58.1x | -11% |
| FY2012 Q1 | Aug 31 2011 | $14.40 | $0.30 | 48.0x | -27% |
| FY2011 Q4 | - | $15.70 | $0.33 | 47.5x | -27% |
| FY2011 Q3 | Feb 28 2011 | $16.82 | $0.51 | 33.0x | -50% |
| FY2011 Q2 | - | $13.97 | $0.49 | 28.5x | -56% |
| FY2011 Q1 | - | $15.22 | $0.49 | 31.1x | -52% |
| FY2010 Q4 | May 31 2010 | $14.77 | $0.50 | 29.5x | -55% |
| FY2010 Q3 | Feb 28 2010 | $16.26 | $0.47 | 34.6x | -47% |
| FY2010 Q2 | Nov 30 2009 | $15.55 | $0.42 | 37.0x | -43% |
| FY2010 Q1 | Aug 31 2009 | $12.95 | $0.41 | 31.6x | -52% |
| FY2009 Q4 | May 31 2009 | $12.30 | $0.41 | 30.0x | -54% |
| FY2009 Q3 | Feb 28 2009 | $11.87 | $0.31 | 38.2x | -42% |
| FY2009 Q2 | Nov 30 2008 | $11.93 | $0.43 | 27.7x | -58% |
| FY2009 Q1 | Aug 31 2008 | $16.43 | $0.44 | 37.3x | -43% |
| FY2008 Q4 | May 31 2008 | $15.49 | $0.45 | 34.3x | -47% |
| FY2008 Q3 | Feb 29 2008 | $16.58 | $0.55 | 30.1x | -54% |
| FY2007 Q2 | Dec 02 2006 | $21.18 | $0.54 | 39.2x | -40% |
| FY2007 Q1 | Sep 02 2006 | $18.09 | $0.52 | 34.8x | -47% |
| FY2006 Q4 | May 31 2006 | $28.00 | $0.50 | 56.0x | -14% |
| FY2006 Q3 | Feb 25 2006 | $25.31 | $0.50 | 50.6x | -23% |
| FY2006 Q2 | Nov 26 2005 | $20.07 | $0.45 | 44.6x | -32% |
| FY2006 Q1 | Aug 27 2005 | $22.17 | $0.41 | 54.1x | -17% |
| FY2005 Q4 | - | $19.77 | $0.37 | 53.4x | -18% |
| FY2005 Q3 | Feb 26 2005 | $21.73 | $0.37 | 58.7x | -10% |
Average P/E for displayed period: 65.4x
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
21+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
ANGO — Frequently Asked Questions
Quick answers to the most common questions about buying ANGO stock.
What is ANGO's P/E ratio?
AngioDynamics, Inc. (ANGO) trailing twelve-month P/E ratio is -14.6x, based on TTM diluted EPS of $-0.67. The 5-year average P/E is 93.3x and the historical range spans 8.9x to 327.1x.
Is ANGO stock overvalued or undervalued?
ANGO trades at -14.6x P/E, below its 5-year average of 93.3x. At the 0th percentile of its historical range (8.9x–327.1x), the stock is priced at a discount to its own history.
Is ANGO stock expensive?
No, ANGO is not expensive on a historical basis. The current P/E of -14.6x is below the 5-year average of 93.3x and sits at the 0th percentile of its valuation range.
What is ANGO's historical P/E range?
Over the past 5 years, ANGO's P/E ratio has ranged from 8.9x to 327.1x, with a median of 58.1x and an average of 93.3x. The current P/E of -14.6x places the stock at the 0th percentile of this range. Full historical data spans 2005–2024.
How does ANGO's P/E compare to the S&P 500?
ANGO trades at -14.6x P/E versus the S&P 500 median of 24.4x. The 160% discount to the market suggests lower growth expectations or perceived higher risk.
How does ANGO's valuation compare to Healthcare peers?
AngioDynamics, Inc. P/E of -14.6x compares to the Healthcare sector median of 22.1x. The discount suggests lower growth expectations, weaker margins, or higher perceived risk relative to peers. See the peer comparison table on this page for ticker-by-ticker P/E and PEG.
What is ANGO's PEG ratio?
ANGO PEG ratio is N/A, based on a P/E of -14.6x and EPS growth of 81.9%. PEG normalises P/E by growth and helps compare stocks with different earnings trajectories.
What is ANGO's earnings yield?
ANGO earnings yield is N/A, the inverse of its -14.6x P/E ratio. Earnings yield represents the percentage of each dollar invested that the company earns. It can be compared directly to bond yields to assess relative attractiveness of stocks versus fixed income.